- Previous Close
10.42 - Open
10.32 - Bid 10.48 x --
- Ask 10.49 x --
- Day's Range
10.28 - 10.55 - 52 Week Range
8.72 - 11.95 - Volume
16,475,015 - Avg. Volume
22,294,416 - Market Cap (intraday)
29.897B - Beta (5Y Monthly) 0.29
- PE Ratio (TTM)
11.15 - EPS (TTM)
0.94 - Earnings Date --
- Forward Dividend & Yield 0.60 (5.69%)
- Ex-Dividend Date Nov 22, 2024
- 1y Target Est
--
MeiHua Holdings Group Co.,Ltd, a synthetic biology company, provides amino acid nutrition and health solutions in China and internationally. The company offers amino acid for feed comprising valine, L-lysine sulphate and HCL, L-threonine, L-tryptophane, corn gluten meal for feedstuffs, corn husk powder, residue of monosodium glutamate, added corn husk powder, and boutique MSG residue; condiments, including monosodium glutamate (MSG); and colloids; enteric, cellulose, gelatin, and pullulan capsules; and fertilizers, which include soil conditioners. It also provides food taste and trait improving products, including glutamic acid, sodium and monosodium glutamate, disodium 5' ribonucleotide and nucleotide, disodium inosinate, 5-inosine acid disodium, food-grade xanthan gum, trehalose, and natamycin; human medical amino acids comprising glutamine, proline, leucine, isoleucine, pharmaceutical valine, inosine, guanosine, adenosine, pullulan, vitamin B2, etc.; and other products, such as petroleum-grade xanthan gum, bio-organic fertilizer, etc. MeiHua Holdings Group Co.,Ltd was founded in 1995 and is headquartered in Langfang, China.
www.meihuagrp.com12,858
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 600873.SS
View MorePerformance Overview: 600873.SS
Trailing total returns as of 4/3/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 600873.SS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 600873.SS
View MoreValuation Measures
Market Cap
29.90B
Enterprise Value
28.91B
Trailing P/E
11.15
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.22
Price/Book (mrq)
2.05
Enterprise Value/Revenue
1.15
Enterprise Value/EBITDA
6.08
Financial Highlights
Profitability and Income Statement
Profit Margin
10.93%
Return on Assets (ttm)
8.32%
Return on Equity (ttm)
19.07%
Revenue (ttm)
25.07B
Net Income Avi to Common (ttm)
2.74B
Diluted EPS (ttm)
0.94
Balance Sheet and Cash Flow
Total Cash (mrq)
5.13B
Total Debt/Equity (mrq)
26.31%
Levered Free Cash Flow (ttm)
2.26B